KO-2806 Monotherapy and Combination Therapies in Advanced Solid Tumors
Conditions
- Solid Tumors With HRAS Alterations
- Non Small Cell Lung Cancer (NSCLC)
- Colorectal Cancer (CRC)
- Pancreatic Ductal Adenocarcinoma (PDAC)
- Clear Cell Renal Cell Carcinoma (ccRCC)
- Renal Cell Carcinoma (Kidney Cancer)
- Non Clear Cell Renal Cell Carcinoma (nccRCC)
Interventions
- DRUG: Darlifarnib
- DRUG: Cabozantinib
- DRUG: Adagrasib
Sponsor
Kura Oncology, Inc.
Collaborators